Fader AN - Search Results

1

Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.

Boruta DM 2nd, Gehrig PA, Fader AN, Olawaiye AB. Boruta DM 2nd, et al. Among authors: fader an. Gynecol Oncol. 2009 Oct;115(1):142-153. doi: 10.1016/j.ygyno.2009.06.011. Epub 2009 Jul 9. Gynecol Oncol. 2009. PMID: 19592079 Review.

2

Role of surgery in ovarian carcinoma.

Fader AN, Rose PG. Fader AN, et al. J Clin Oncol. 2007 Jul 10;25(20):2873-83. doi: 10.1200/JCO.2007.11.0932. J Clin Oncol. 2007. PMID: 17617518 Review.

3

Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.

Axtell AE, Kelley JL, Fader AN, Gupta D, Schwartz B, Comerci JT, Lin Y, Weiand S, Gallion HH, Kanbour-Shakir A. Axtell AE, et al. Among authors: fader an. Gynecol Oncol. 2007 Dec;107(3):482-6. doi: 10.1016/j.ygyno.2007.08.004. Epub 2007 Sep 11. Gynecol Oncol. 2007. PMID: 17850853

4

Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.

Moore KN, Moxley KM, Fader AN, Axtell AE, Rocconi RP, Abaid LN, Cass IA, Rose PG, Leath CA 3rd, Rutledge T, Blankenship D, Gold MA. Moore KN, et al. Among authors: fader an. Gynecol Oncol. 2007 Dec;107(3):398-403. doi: 10.1016/j.ygyno.2007.09.027. Epub 2007 Nov 7. Gynecol Oncol. 2007. PMID: 17997146

5

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.

Fader AN, von Gruenigen V, Gibbons H, Abushahin F, Starks D, Markman M, Belinson J, Rose P. Fader AN, et al. Gynecol Oncol. 2008 Apr;109(1):33-8. doi: 10.1016/j.ygyno.2008.01.001. Epub 2008 Feb 7. Gynecol Oncol. 2008. PMID: 18261784

6

Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment.

Fader AN, Edwards RP, Cost M, Kanbour-Shakir A, Kelley JL, Schwartz B, Sukumvanich P, Comerci J, Sumkin J, Elishaev E, Rohan LC. Fader AN, et al. Gynecol Oncol. 2008 Oct;111(1):13-7. doi: 10.1016/j.ygyno.2008.06.009. Epub 2008 Aug 5. Gynecol Oncol. 2008. PMID: 18684499

7

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.

Fader AN, Nagel C, Axtell AE, Zanotti KM, Kelley JL, Moore KN, Secord AA, Walsh CS, Huh WK, Gehrig PA, Gibbons H, Rose PG, Havrilesky LJ, Tuller E, Drake RD, Bottsford-Miller J, O'Malley DM; UPSC Consortium. Fader AN, et al. Gynecol Oncol. 2009 Mar;112(3):558-62. doi: 10.1016/j.ygyno.2008.11.016. Epub 2009 Jan 1. Gynecol Oncol. 2009. PMID: 19118888

8

Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.

Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, Gehrig PA, Tuller E, Axtell AE, Zanotti KM; Uterine Papillary Serous Carcinoma (UPSC) Consortium. Fader AN, et al. Cancer. 2009 May 15;115(10):2119-27. doi: 10.1002/cncr.24247. Cancer. 2009. PMID: 19306417 Free article.

9

Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.

Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Fader AN, et al. Gynecol Oncol. 2009 Jul;114(1):121-7. doi: 10.1016/j.ygyno.2009.03.039. Epub 2009 Apr 29. Gynecol Oncol. 2009. PMID: 19406460 Review.

10

Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report.

Fader AN, Escobar PF. Fader AN, et al. Gynecol Oncol. 2009 Aug;114(2):157-61. doi: 10.1016/j.ygyno.2009.05.020. Epub 2009 May 28. Gynecol Oncol. 2009. PMID: 19481243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page